Ownership

Adam Crystal - Insider Trading & Ownership

Entity: Individual
Location: C4 Therapeutics, Inc., 490 Arsenal Way, Suite 200, Watertown, MA
Summary: The estimated net worth of Adam Crystal is at least $750K dollars as of February 6, 2025. Adam Crystal is the President, Research & Development of Tango Therapeutics, Inc. and owns shares of Tango Therapeutics, Inc. (TNGX) stock worth about $500K. Adam Crystal is the Chief Medical Officer of C4 Therapeutics, Inc. and owns shares of C4 Therapeutics, Inc. (CCCC) stock worth about $250K.
All Insider Reports: All Insider Reports

Ownership of Adam Crystal

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
TNGX	Tango Therapeutics, Inc.	President, Research & Development	$500K	-$43.9K	-8.06%	Feb 4, 2025
CCCC	C4 Therapeutics, Inc.	Chief Medical Officer	$250K			Jan 30, 2023

Showing 1 to 2 of 2 entries

Insider Transactions Reported by Adam Crystal:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
TNGX	Tango Therapeutics, Inc.	Common Stock	Sale	-4.15%	-$21.7K	3.16	-6.85K	158K	2/5/2025	Direct
TNGX	Tango Therapeutics, Inc.	Common Stock	Sale	-4.31%	-$22.2K	2.99	-7.43K	165K	2/4/2025	Direct
TNGX	Tango Therapeutics, Inc.	Common Stock	Award	+44.4%	$0	0.00	+53K	172K	2/3/2025	Direct
TNGX	Tango Therapeutics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+318K	318K	2/3/2025	Direct
TNGX	Tango Therapeutics, Inc.	Common Stock	Sale	-3.3%	-$51.5K	12.62	-4.08K	119K	2/7/2024	Direct
TNGX	Tango Therapeutics, Inc.	Common Stock	Sale	-3.35%	-$53.9K	12.56	-4.29K	124K	2/6/2024	Direct
TNGX	Tango Therapeutics, Inc.	Common Stock	Award		$0	0.00	+46.6K	46.6K	2/1/2024	Direct
TNGX	Tango Therapeutics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+280K	280K	2/1/2024	Direct
TNGX	Tango Therapeutics, Inc.	Common Stock	Sale	-8.46%	-$63K	8.39	-7.51K	81.3K	11/1/2023	Direct
TNGX	Tango Therapeutics, Inc.	Common Stock	Award		$0	0.00	+81.3K	81.3K	3/1/2023	Direct
TNGX	Tango Therapeutics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+488K	488K	3/1/2023	Direct
CCCC	C4 Therapeutics, Inc.	Common Stock	Options Exercise	+21.3%	$0		+3.75K	21.4K	1/30/2023	Direct
CCCC	C4 Therapeutics, Inc.	Common Stock	Tax liability	-6.08%	-$10.1K	7.78	-1.3K	20.1K	1/30/2023	Direct
CCCC	C4 Therapeutics, Inc.	Performance Restricted Stock Units	Options Exercise	-16.7%	$0	0.00	-3.75K	18.8K	1/30/2023	Direct
CCCC	C4 Therapeutics, Inc.	Common Stock	Tax liability	-5.88%	-$7.73K	7.01	-1.1K	17.6K	5/26/2022	Direct
CCCC	C4 Therapeutics, Inc.	Common Stock	Options Exercise	+25%	$0		+3.75K	18.8K	5/25/2022	Direct
CCCC	C4 Therapeutics, Inc.	Performance Restricted Stock Units	Options Exercise	-14.3%	$0	0.00	-3.75K	22.5K	5/25/2022	Direct
CCCC	C4 Therapeutics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+118K	118K	2/14/2022	Direct
CCCC	C4 Therapeutics, Inc.	Performance Restricted Stock Units	Award		$0	0.00	+26.3K	26.3K	2/14/2022	Direct
CCCC	C4 Therapeutics, Inc.	Common Stock	Sale	-50%	-$475K	31.66^*	-15K	15K	1/4/2022	Direct
CCCC	C4 Therapeutics, Inc.	Common Stock	Options Exercise	+100%	$97.4K	6.49	+15K	30K	1/4/2022	Direct
CCCC	C4 Therapeutics, Inc.	Stock Option (Right to Buy)	Options Exercise	-11.8%	$0	0.00	-15K	112K	1/4/2022	Direct
CCCC	C4 Therapeutics, Inc.	Common Stock	Options Exercise	+50%	$32.5K	6.49	+5K	15K	12/22/2021	Direct
CCCC	C4 Therapeutics, Inc.	Stock Option (Right to Buy)	Options Exercise	-3.78%	$0	0.00	-5K	127K	12/22/2021	Direct
CCCC	C4 Therapeutics, Inc.	Common Stock	Options Exercise		$64.9K	6.49	+10K	10K	10/8/2021	Direct
CCCC	C4 Therapeutics, Inc.	Stock Option (Right to Buy)	Options Exercise	-7.03%	$0	0.00	-10K	132K	10/8/2021	Direct
CCCC	C4 Therapeutics, Inc.	Common Stock	Options Exercise		$74.7K	4.98	+15K	15K	10/1/2021	Direct
CCCC	C4 Therapeutics, Inc.	Common Stock	Sale	-100%	-$681K	45.43^*	-15K	0	10/1/2021	Direct
CCCC	C4 Therapeutics, Inc.	Stock Option (Right to Buy)	Options Exercise	-8.19%	$0	0.00	-15K	168K	10/1/2021	Direct
CCCC	C4 Therapeutics, Inc.	Common Stock	Sale	-100%	-$675K	45.00^*	-15K	0	7/29/2021	Direct
CCCC	C4 Therapeutics, Inc.	Common Stock	Options Exercise		$74.7K	4.98	+15K	15K	7/29/2021	Direct
CCCC	C4 Therapeutics, Inc.	Stock Option (Right to Buy)	Options Exercise	-7.57%	$0	0.00	-15K	183K	7/29/2021	Direct
CCCC	C4 Therapeutics, Inc.	Common Stock	Options Exercise		$97.5K	6.50	+15K	15K	7/1/2021	Direct
CCCC	C4 Therapeutics, Inc.	Common Stock	Sale	-100%	-$570K	37.98^*	-15K	0	7/1/2021	Direct
CCCC	C4 Therapeutics, Inc.	Stock Option (Right to Buy)	Options Exercise	-9.54%	$0	0.00	-15K	142K	7/1/2021	Direct

Previous1Next

Showing 1 to 35 of 35 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.